WASHINGTON (Reuters) - Breast cancer patients with lower levels of vitamin D were far more likely to die and far more likely to have their cancer spread than women with normal levels, Canadian researchers reported on Thursday.
WASHINGTON (Reuters) - Breast cancer patients who get newer scans called magnetic resonance imaging are more likely to opt for mastectomies, U.S. researchers reported on Thursday.
CHICAGO (Reuters) - Children who survive cancer while they are young are five to 10 times more likely than their healthy siblings to develop heart disease, U.S. researchers said on Thursday.
GENEVA (Reuters) - Obesity contributes to global warming, too.
WASHINGTON (Reuters) - A drug prescribed to prevent fractures in breast cancer patients whose tumors have spread may actually help slow the cancer itself, U.S. researchers reported on Thursday.
TORONTO (Reuters) - The so-called "morning after" pill Plan B has received full over-the-counter status in Canada, drug maker Paladin Labs Inc said on Thursday.
BANGKOK (Reuters) - An international aid agency has confirmed some cases of cholera in Myanmar's cyclone-hit Irawaddy delta but the number was in line with normal levels in previous years, an aid official said on Friday.
OTTAWA (Reuters) - Canada said on Friday it was scrapping work on a trouble-plagued nuclear reactor designed to produce medical isotopes but vowed to maintain output by continuing to use an older reactor.
NEW YORK (Reuters Health) - Obesity is a well known risk factor for certain physical health problems, but a new study suggests that heavy adults also have higher rates of psychiatric disorders.
WASHINGTON (Reuters) - U.S. health officials on Thursday recommended that people 60 and older get Merck & Co Inc's vaccine Zostavax to protect against shingles, a viral infection that causes a painful, blistering rash.
LOS ANGELES (Reuters) - Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.
WASHINGTON (Reuters) - Nearly two-thirds of kidney cancer patients taking Novartis AG's RAD001 had progression of their disease delayed by a year, a significantly better result than in those taking placebo, investigators said.
NEW YORK (Reuters Health) - People who snack on popcorn may consume more whole grains and less meat than their peers who don't, new research shows.
WASHINGTON (Reuters) - Lung cancer patients who took Eli Lilly and Co's Alimta after finishing their normal course of chemotherapy lived 40 percent longer without any tumor progression than patients who took a placebo, researchers reported on Thursday.
ROCKVILLE, Maryland (Reuters) - Ads for prescription drugs need to be clear and direct and government needs to study the effects these ads have on consumer behavior, particularly among the elderly and minorities, a U.S. Food and Drug Administration panel of outside experts said on Thursday.
NEW YORK (Reuters Health) - Contaminated dry dog food was the source of an outbreak of Salmonella infections affecting people in 19 states, public health officials report in the Morbidity and Mortality Weekly Report, a publication of the U.S. Centers for Disease Control and Prevention.
NEW YORK (Reuters Health) - While many people who sprain an ankle get back on their feet quickly, some continue to have pain and other problems for months to years, a new study shows.
NEW YORK (Reuters) - Johnson & Johnson said on Thursday it was voluntarily recalling specific lots of three of its medicines to protect patients from receiving potentially mishandled or damaged products after a truck carrying the drugs was stolen.
NEW YORK (Reuters Health) - Blocking parts of the nervous system that regulate body temperature can reduce hot flashes and improve sleep in survivors of breast cancer, researchers reported on Thursday.
NEW YORK (Reuters Health) - High-doses of cholesterol-lowering statins that are "lipophilic" -- meaning they are soluble in fats -- may offer protection against cancer, according to a new study that found a significant reduction in the incidence of cancer in users of these statins.
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.